dc.contributor.author |
Luo, Sheng |
|
dc.contributor.author |
Zou, Haotian |
|
dc.contributor.author |
Goetz, Christopher G |
|
dc.contributor.author |
Choi, Dongrak |
|
dc.contributor.author |
Oakes, David |
|
dc.contributor.author |
Simuni, Tanya |
|
dc.contributor.author |
Stebbins, Glenn T |
|
dc.date.accessioned |
2021-10-01T13:22:04Z |
|
dc.date.available |
2021-10-01T13:22:04Z |
|
dc.date.issued |
2021-01-01 |
|
dc.identifier.issn |
2330-1619 |
|
dc.identifier.issn |
2330-1619 |
|
dc.identifier.uri |
https://hdl.handle.net/10161/23865 |
|
dc.description.abstract |
Background: Although nontremor and tremor Part 3 Movement Disorder Society–Unified
Parkinson's Disease Rating Scale items measure different impairment domains, their
distinct progression and drug responsivity remain unstudied longitudinally. The total
score may obscure important time-based and treatment-based changes occurring in the
individual domains. Objective: Using the unique advantages of item response theory
(IRT), we developed novel longitudinal unidimensional and multidimensional models
to investigate nontremor and tremor changes occurring in an interventional Parkinson's
disease (PD) study. Method: With unidimensional longitudinal IRT, we assessed the
33 Part 3 item data (22 nontremor and 10 tremor items) of 336 patients with early
PD from the STEADY-PD III (Safety, Tolerability, and Efficacy Assessment of Isradipine
for PD, placebo vs. isradipine) study. With multidimensional longitudinal IRT, we
assessed the progression rates over time and treatment (in overall motor severity,
nontremor, and tremor domains) using Markov Chain Monte Carlo implemented in Stan.
Results: Regardless of treatment, patients showed significant but different time-based
deterioration rates for total motor, nontremor, and tremor scores. Isradipine was
associated with additional significant deterioration over placebo in total score and
nontremor scores, but not in tremor score. Further highlighting the 2 separate latent
domains, nontremor and tremor severity changes were positively but weakly correlated
(correlation coefficient, 0.108). Conclusions: Longitudinal IRT analysis is a novel
statistical method highly applicable to PD clinical trials. It addresses limitations
of traditional linear regression approaches and previous IRT investigations that either
applied cross-sectional IRT models to longitudinal data or failed to estimate all
parameters simultaneously. It is particularly useful because it can separate nontremor
and tremor changes both over time and in response to treatment interventions.
|
|
dc.language |
en |
|
dc.publisher |
Wiley |
|
dc.relation.ispartof |
Movement Disorders Clinical Practice |
|
dc.relation.isversionof |
10.1002/mdc3.13311 |
|
dc.title |
Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale
Monitoring in Clinical Trials: Longitudinal Item Response Theory Models
|
|
dc.type |
Journal article |
|
duke.contributor.id |
Luo, Sheng|0796693 |
|
duke.contributor.id |
Zou, Haotian|1253606 |
|
dc.date.updated |
2021-10-01T13:22:04Z |
|
pubs.organisational-group |
School of Medicine |
|
pubs.organisational-group |
Duke Clinical Research Institute |
|
pubs.organisational-group |
Biostatistics & Bioinformatics |
|
pubs.organisational-group |
Duke |
|
pubs.organisational-group |
Institutes and Centers |
|
pubs.organisational-group |
Basic Science Departments |
|
pubs.publication-status |
Published |
|
duke.contributor.orcid |
Luo, Sheng|0000-0003-4214-5809 |
|
duke.contributor.orcid |
Zou, Haotian|0000-0002-3595-8716 |
|